Wordt geladen...
Nanoparticle formulation and in vitro efficacy testing of the mitoNEET ligand NL-1 for drug delivery in a brain endothelial model of ischemic reperfusion-injury
Ischemic reperfusion injury after a stroke is a leading cause of mortality and disability due to neuronal loss and tissue damage. Mitochondrial dysfunction plays a major role in the reperfusion-injury sequelae, and offers an attractive drug target. Mitochondrial derived reactive oxygen species (ROS)...
Bewaard in:
| Gepubliceerd in: | Int J Pharm |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7067674/ https://ncbi.nlm.nih.gov/pubmed/32004683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpharm.2020.119090 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|